Skip to main content

Table 2 94 lipid biomarker target information

From: Integrated lipidomics and network pharmacology analysis to reveal the mechanisms of berberine in the treatment of hyperlipidemia

ALG3

PEMT

LYPLA1

CEL

B3GNT2

FUT9

B4GALT7

PLCD3

LYPLA2

CLC

PLA2G4E

DGKK

DGKA

DGKB

DGKG

DGKH

DGKQ

B3GNT6

STT3B

PLCH1

PLCL2

PLCB1

CLCF1

LYPLA3

PISD

PLA2G4F

PLA2G2D

GBA

GBGT1

B4GALT1

GLB1

PLA2G4D

LGALS13

PLA2G2E

MOGAT3

STT3A

LCAT

LCT

LIPA

LIPB

LIPC

PLA2G3

PLCE1

GALNT7

PLA2G1B

PLA2G2A

PLA2G4A

PLA2G5

PLCB2

PLCB3

PLCB4

PLCD1

PLCG1

PLCG2

PLD1

PLD2

PNLIP

PNLIPRP1

PNLIPRP2

AGK

CHPT1

AASDHPPT

PLA2G2F

SOAT1

UGCG

ALG12

GLB1L

PNPLA3

PLA2G12A

PLA2G6

PLA2G10

SOAT2

PLA2G12B

DGAT2

PLCD4

LIPF

DGKZ

DGKE

DGKD

ALG2

PLA2G4C

PPAP2A

PPAP2C

PPAP2B

LOC100137047-PLA2G4B

DGAT1

B4GALT4

B4GALT3

B4GALT2

PLCZ1

DGKI

B4GALT5

LIPG

PLCH2